![Abel de la Rosa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Abel de la Rosa
Direktor/Vorstandsmitglied bei VIRIOS THERAPEUTICS, INC.
Aktive Positionen von Abel de la Rosa
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIRIOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.12.2020 | - |
Independent Dir/Board Member | 21.12.2020 | - | |
Antios Therapeutics, Inc.
![]() Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Vorsitzender | 01.12.2020 | - |
Gründer | - | - | |
Direktor/Vorstandsmitglied | - | 01.12.2020 | |
Vorstandsvorsitzender | - | 01.12.2020 |
Karriereverlauf von Abel de la Rosa
Ehemalige bekannte Positionen von Abel de la Rosa
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Celtaxsys, Inc.
![]() Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Direktor/Vorstandsmitglied | 01.01.2012 | 01.01.2020 |
Drug Innovation Ventures At Emory LLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.01.2018 |
Emory Institute For Drug Development
![]() Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.01.2018 |
Pharmasset, Inc.
![]() Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | 01.01.2012 |
Ausbildung von Abel de la Rosa
Miami University | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VIRIOS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Pharmasset, Inc.
![]() Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Celtaxsys, Inc.
![]() Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
Drug Innovation Ventures At Emory LLC | |
Emory Institute For Drug Development
![]() Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Commercial Services |
Antios Therapeutics, Inc.
![]() Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Health Technology |
- Börse
- Insiders
- Abel de la Rosa
- Erfahrung